• 2022
  van der Put RMF, Smitsman C, de Haan A, Hamzink M, Timmermans H, Uittenbogaard J, Westdijk J, Stork M, Ophorst O, Thouron F, Guerreiro C, Sansonetti PJ, Phalipon A, Mulard LA, , The First-in-Human Synthetic Glycan-Based Conjugate Vaccine Candidate against Shigella., ACS Cent Sci 2022 Apr; 8(4): 449-460.
• 2015
  Rossi O, Baker KS, Phalipon A, Weill FX, Citiulo F, Sansonetti P, Gerke C, Thomson NR, Draft genomes of Shigella strains used by the STOPENTERICS consortium, Gut Pathog 2015;7:14.
• 2015
  Phalipon A, Editorial, Semin. Immunol. 2015 Mar;27(2):73-4.
• 2015
  Nothelfer K, Sansonetti PJ, Phalipon A, Pathogen manipulation of B cells: the best defence is a good offence, Nat. Rev. Microbiol. 2015 Mar;13(3):173-84.
• 2014
  Gauthier C, Chassagne P, Theillet FX, Guerreiro C, Thouron F, Nato F, Delepierre M, Sansonetti PJ, Phalipon A, Mulard LA, Non-stoichiometric O-acetylation of Shigella flexneri 2a O-specific polysaccharide: synthesis and antigenicity, Org. Biomol. Chem. 2014 Jun;12(24):4218-32.
• 2014
  Nothelfer K, Arena ET, Pinaud L, Neunlist M, Mozeleski B, Belotserkovsky I, Parsot C, Dinadayala P, Burger-Kentischer A, Raqib R, Sansonetti PJ, Phalipon A, B lymphocytes undergo TLR2-dependent apoptosis upon Shigella infection., J Exp Med 2014 Jun; 211(6): 1215-29.
• 2014
  Salgado-Pabón W, Konradt C, Sansonetti PJ, Phalipon A, New insights into the crosstalk between Shigella and T lymphocytes, Trends Microbiol. 2014 Apr;22(4):192-8.
• 2011
  Theillet FX, Frank M, Vulliez-Le Normand B, Simenel C, Hoos S, Chaffotte A, Bélot F, Guerreiro C, Nato F, Phalipon A, Mulard LA, Delepierre M, Dynamic aspects of antibody:oligosaccharide complexes characterized by molecular dynamics simulations and saturation transfer difference nuclear magnetic resonance, Glycobiology 2011 Dec;21(12):1570-9.
• 2011
  Konradt C, Frigimelica E, Nothelfer K, Puhar A, Salgado-Pabon W, di Bartolo V, Scott-Algara D, Rodrigues CD, Sansonetti PJ, Phalipon A, , The Shigella flexneri type three secretion system effector IpgD inhibits T cell migration by manipulating host phosphoinositide metabolism., Cell Host Microbe 2011 Apr; 9(4): 263-72.
• 2011
  Nothelfer K, Dias Rodrigues C, Bobard A, Phalipon A, Enninga J, Monitoring Shigella flexneri vacuolar escape by flow cytometry, Virulence 2011 Jan-Feb;2(1):54-7.
• 2010
  Theillet FX, Simenel C, Guerreiro C, Phalipon A, Mulard LA, Delepierre M, Effects of backbone substitutions on the conformational behavior of Shigella flexneri O-antigens: implications for vaccine strategy, Glycobiology 2011 Jan;21(1):109-21.
• 2010
  Sellge G, Magalhaes JG, Konradt C, Fritz JH, Salgado-Pabon W, Eberl G, Bandeira A, Di Santo JP, Sansonetti PJ, Phalipon A, Th17 cells are the dominant T cell subtype primed by Shigella flexneri mediating protective immunity, J. Immunol. 2010 Feb;184(4):2076-85.
• 2009
  Theillet FX, Saul FA, Vulliez-Le Normand B, Hoos S, Felici F, Weintraub A, Mulard LA, Phalipon A, Delepierre M, Bentley GA, Structural mimicry of O-antigen by a peptide revealed in a complex with an antibody raised against Shigella flexneri serotype 2a, J. Mol. Biol. 2009 May;388(4):839-50.
• 2009
  Phalipon A, Tanguy M, Grandjean C, Guerreiro C, Bélot F, Cohen D, Sansonetti PJ, Mulard LA, A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection, J. Immunol. 2009 Feb;182(4):2241-7.
• 2008
  Phalipon A, Mulard LA, Sansonetti PJ, Vaccination against shigellosis: is it the path that is difficult or is it the difficult that is the path?, Microbes Infect. 2008 Jul;10(9):1057-62.
• 2007
  Nato F, Phalipon A, Nguyen TL, Diep TT, Sansonetti P, Germani Y, Dipstick for rapid diagnosis of Shigella flexneri 2a in stool, PLoS ONE 2007;2(4):e361.
• 2007
  Phalipon A, Sansonetti PJ, Shigella’s ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival?, Immunol. Cell Biol. 2007 Feb-Mar;85(2):119-29.
• 2005
  Clément MJ, Fortuné A, Phalipon A, Marcel-Peyre V, Simenel C, Imberty A, Delepierre M, Mulard LA, Toward a better understanding of the basis of the molecular mimicry of polysaccharide antigens by peptides: the example of Shigella flexneri 5a, J. Biol. Chem. 2006 Jan;281(4):2317-32.
• 2004
  Bélot F, Wright K, Costachel C, Phalipon A, Mulard LA, Blockwise approach to fragments of the O-specific polysaccharide of Shigella flexneri serotype 2a: convergent Synthesis of a decasaccharide representative of a dimer of the branched repeating unit, J. Org. Chem. 2004 Feb;69(4):1060-74.
• 2003
  Clément MJ, Imberty A, Phalipon A, Pérez S, Simenel C, Mulard LA, Delepierre M, Conformational studies of the O-specific polysaccharide of Shigella flexneri 5a and of four related synthetic pentasaccharide fragments using NMR and molecular modeling, J. Biol. Chem. 2003 Nov;278(48):47928-36.
• 2003
  Fernandez MI, Pedron T, Tournebize R, Olivo-Marin JC, Sansonetti PJ, Phalipon A, Anti-inflammatory role for intracellular dimeric immunoglobulin a by neutralization of lipopolysaccharide in epithelial cells, Immunity 2003 Jun;18(6):739-49.
• 2003
  Phalipon A, Corthésy B, Novel functions of the polymeric Ig receptor: well beyond transport of immunoglobulins, Trends Immunol. 2003 Feb;24(2):55-8.
• 2003
  Phalipon A, Sansonetti PJ, Shigellosis: innate mechanisms of inflammatory destruction of the intestinal epithelium, adaptive immune response, and vaccine development, Crit. Rev. Immunol. 2003;23(5-6):371-401.